Richard Pzena's REGN Position Overview
Richard Pzena (via Pzena Investment Management LLC) currently holds 409 shares of Regeneron Pharmaceuticals, Inc. (REGN) worth $310,132, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Richard Pzena has maintained a strategic position in REGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 409 shares. Largest reduction occurred in Q4 2022, reducing 794 shares.
Analysis based on 13F filings available since 2013 Q2
Richard Pzena's Regeneron Pharmaceuticals (REGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Regeneron Pharmaceuticals (REGN) Trades by Richard Pzena
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +409 | New Buy | 409 | $758.27 |
| Q4 2022 | -794 | Sold Out | 0 | $0.00 |
| Q3 2022 | -325 | Reduce 29.04% | 794 | $688.92 |
| Q2 2022 | +195 | Add 21.10% | 1,119 | $590.71 |
| Q1 2022 | +20 | Add 2.21% | 924 | $698.05 |
| Q4 2021 | -73 | Reduce 7.47% | 904 | $631.64 |
| Q3 2021 | -137 | Reduce 12.30% | 977 | $604.91 |
| Q2 2021 | -141 | Reduce 11.24% | 1,114 | $558.35 |
| Q1 2021 | +1,255 | New Buy | 1,255 | $473.31 |
Richard Pzena's Regeneron Pharmaceuticals Investment FAQs
Richard Pzena first purchased Regeneron Pharmaceuticals, Inc. (REGN) in Q1 2021, acquiring 1,255 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Richard Pzena has held Regeneron Pharmaceuticals, Inc. (REGN) for 9 quarters since Q1 2021.
Richard Pzena's largest addition to Regeneron Pharmaceuticals, Inc. (REGN) was in Q1 2021, adding 1,255 shares worth $594,000.
According to the latest 13F filing for Q3 2026, Richard Pzena's firm, Pzena Investment Management LLC, owns 409 shares of Regeneron Pharmaceuticals, Inc. (REGN), valued at approximately $310,132.
As of the Q3 2026 filing, Regeneron Pharmaceuticals, Inc. (REGN) represents approximately 0.00% of Richard Pzena's publicly disclosed stock portfolio, making it one of their key holdings.
Richard Pzena's peak holding in Regeneron Pharmaceuticals, Inc. (REGN) was 1,255 shares, as reported at the end of Q1 2021.